We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Symphogen’s Antibody Mixtures Highlighted in Three Peer-Reviewed Journals

News   May 28, 2015

 
Symphogen’s Antibody Mixtures Highlighted in Three Peer-Reviewed Journals
 
 
Advertisement
 

RELATED ARTICLES

Team Uncovers New Mechanism of Action Against SARS-CoV-2 by Remdesivir

News

Researchers have discovered a novel, second mechanism of action by the antiviral drug remdesivir against SARS-CoV-2, according to findings published in the Journal of Biological Chemistry.

READ MORE

Growth Factor R-spondin Suppresses Colorectal Cancer Growth

News

R-spondin, which enhances the growth of normal cells in the gut, suppresses the growth of intestinal cancer cells, thus reducing the formation of intestinal tumors, according to a new study.

READ MORE

$111 Million NIH Grant Awarded To Combat HIV-Associated Cancers

News

For 25 years, the AIDS Malignancy Consortium (AMC) has led national and international efforts to prevent and treat of HIV-related cancers. Now, Montefiore Health System and Albert Einstein College of Medicine have received a five-year, $111 million grant from the National Cancer Institute (NCI) to lead this research consortium.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE